fashion -WSS

fashion

author：entertainment 2025-10-02 11:09:15 - browse：932

Eli Lilly headquarters — Kristoffer Tripplaar/AP

SAN DIEGO – An experimental pill from Eli Lilly led to 14.7% weight loss on the highest dose in a 36-week trial, heating up the growing competition among drugmakers to develop an effective oral obesity therapy.

The mid-stage results for orforglipron match the estimates of 14-15% weight loss that Lilly gave in an investor call late last year. The full results, published Friday in the New England Journal of Medicine, were presented here to a packed conference room at the American Diabetes Association conference.

By the end of trial, the authors said, participants’ weight loss had not plateaued, suggesting potential for even greater weight loss over a longer treatment period.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Neuroscience startup Neumora files for IPO

leisure time

WSS

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Google and Epic fight stronger regulation of AI in health care

As pharma fights Medicare drug negotiation, hospitals, docs silent

At Orexo, a ‘turning point’ for everything but digital health

As pharma fights Medicare drug negotiation, hospitals, docs silent

What AAP's gender

hotspot

fashion

focus

Medicare proposal to cover medical devices draws a mixed reaction

Biden tests positive for Covid

Medical records are filled with copy

At Orexo, a ‘turning point’ for everything but digital health

As demand for Covid shots wanes, Moderna seeks its next success

AstraZeneca bets AAV gene therapy will still deliver the goods

23andMe had bad news about my health. I wish a person had delivered it

Psilocybin's anti

Continuity nursing helped my family in our darkest PICU moments

Key House panel plots a new health care package

entertainment

Appeals court upholds limits to abortion pill

Drug firms test therapies to halt Alzheimer’s before symptoms arise

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Complete sequence of Y chromosome published for first time

What do new weight loss drugs mean for bariatric surgery?

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

leisure time

focus

leisure time

leisure time